Perivascular cells and tissue engineering: Current applications and untapped potential

Elisa Avolio, Valeria Vincenza Alvino, Mohamed T Ghorbel, Paola Campagnolo
Published 2017 in Pharmacology & therapeutics

Abstract

The recent development of tissue engineering provides exciting new perspectives for the replacement of failing organs and the repair of damaged tissues. Perivascular cells, including vascular smooth muscle cells, pericytes and other tissue specific populations residing around blood vessels, have been isolated from many organs and are known to participate to… (More)

DOI: 10.1016/j.pharmthera.2016.11.002

5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside reduces intimal hyperplasia of tissue engineering blood vessel by inhibiting phenotype switch of vascular smooth muscle cell.

Yangxiao Wu, Ge Liu, Wen Chen, Mingcan Yang, Chuhong Zhu
Journal of biomedical materials research. Part B…
2017

Perivascular cells and tissue engineering: Current applications and untapped potential

Abstract

Topics

6 Figures and Tables

Cited By

Molecular mechanisms underlying therapeutic potential of pericytes

References

Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation

Perivascular cells for regenerative medicine

Phenotype Modulation in Vascular Tissue Engineering Using Biochemical and Mechanical Stimulation

Human myocardial pericytes: multipotent mesodermal precursors exhibiting cardiac specificity.

3D scaffolds co-seeded with human endothelial progenitor and mesenchymal stem cells: evidence of prevascularisation within 7 days.

Perivascular support of human hematopoietic stem/progenitor cells.

5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside reduces intimal hyperplasia of tissue engineering blood vessel by inhibiting phenotype switch of vascular smooth muscle cell.

Derivation of Endothelial Cells and Pericytes from Human Pluripotent Stem Cells.

Design, fabrication and perivascular implantation of bioactive scaffolds engineered with human adventitial progenitor cells for stimulation of arteriogenesis in peripheral ischemia.

Human mesenchymal stem cells cultured on silk hydrogels with variable stiffness and growth factor differentiate into mature smooth muscle cell phenotype.

Slides referencing similar topics

Perivascular cells and tissue engineering: Current applications and untapped potential

Abstract

Topics

6 Figures and Tables

Cited By

Molecular mechanisms underlying therapeutic potential of pericytes

References

Decellularized human liver as a natural 3D-scaffold for liver bioengineering and transplantation

Perivascular cells for regenerative medicine

Phenotype Modulation in Vascular Tissue Engineering Using Biochemical and Mechanical Stimulation

Human myocardial pericytes: multipotent mesodermal precursors exhibiting cardiac specificity.

3D scaffolds co-seeded with human endothelial progenitor and mesenchymal stem cells: evidence of prevascularisation within 7 days.

Perivascular support of human hematopoietic stem/progenitor cells.

5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside reduces intimal hyperplasia of tissue engineering blood vessel by inhibiting phenotype switch of vascular smooth muscle cell.

Derivation of Endothelial Cells and Pericytes from Human Pluripotent Stem Cells.

Design, fabrication and perivascular implantation of bioactive scaffolds engineered with human adventitial progenitor cells for stimulation of arteriogenesis in peripheral ischemia.

Human mesenchymal stem cells cultured on silk hydrogels with variable stiffness and growth factor differentiate into mature smooth muscle cell phenotype.

Similar Papers

Slides referencing similar topics